Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tomoko SHONO-SAITO"'
Autor:
Takashi Sakai, Yoshitaka Kai, Hiroto Kojima, Kazushi Ishikawa, Tomoko Shono-Saito, Sakuhei Fujiwara, Fumiaki Shimizu, Hidenori Tanaka, Yasunari Yamada, Yutaka Hatano, Tomoko Yamate, Shinsuke Noso, Hiromu Mori, Hiroshi Ikegami
Publikováno v:
European Journal of Dermatology. 27:184-185
Nivolumab is a monoclonal antibody directed against PD1 (programmed cell death 1) that can improve survival in patients with metastatic melanoma. Such immune checkpoint inhibitors have been known to induce type 1 diabetes mellitus (T1D) [1, 2].A 54-y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4305435b8a8f0e6831905437d085c70a
https://doi.org/10.1684/ejd.2016.2923
https://doi.org/10.1684/ejd.2016.2923
Autor:
Kazushi ISHIKAWA, Tomoko SHONO-SAITO, Tomoko YAMATE, Yoshitaka KAI, Takashi SAKAI, Fumiaki SHIMIZU, Yasunari YAMADA, Hiromu MORI, Shinsuke NOSO, Hiroshi IKEGAMI, Hiroto KOJIMA, Hidenori TANAKA, Sakuhei FUJIWARA, Yutaka HATANO
Publikováno v:
European Journal of Dermatology; Mar/Apr2017, Vol. 27 Issue 2, p184-185, 2p